Adeno‐associated virus (AAV)-based gene therapy for glioblastoma

Glioblastoma (GBM) is the most common and malignant Grade IV primary craniocerebral tumor caused by glial cell carcinogenesis with an extremely poor median survival of 12–18 months. The current standard treatments for GBM, including surgical resection followed by chemotherapy and radiotherapy, fail...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Cell Int
Main Authors: Xu, Xin, Chen, Wenli, Zhu, Wenjun, Chen, Jing, Ma, Bin, Ding, Jianxia, Wang, Zaichuan, Li, Yifei, Wang, Yeming, Zhang, Xiaochun
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2021
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7836184/
https://ncbi.nlm.nih.gov/pubmed/33499886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-021-01776-4
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki